Olivier Danos
2020
In 2020, Olivier Danos earned a total compensation of $1.8M as EVP, Chief Scientific Officer at Regenxbio, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,563 |
|---|---|
| Option Awards | $1,181,556 |
| Salary | $433,908 |
| Other | $16,388 |
| Total | $1,805,415 |
Danos received $1.2M in option awards, accounting for 65% of the total pay in 2020.
Danos also received $173.6K in non-equity incentive plan, $433.9K in salary and $16.4K in other compensation.
Rankings
In 2020, Olivier Danos' compensation ranked 5,998th out of 13,090 executives tracked by ExecPay. In other words, Danos earned more than 54.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,998 out of 13,090 | 54th |
Division Manufacturing | 2,471 out of 5,620 | 56th |
Major group Chemicals And Allied Products | 989 out of 2,253 | 56th |
Industry group Drugs | 856 out of 1,953 | 56th |
Industry Biological Products, Except Diagnostic Substances | 208 out of 411 | 49th |
Source: SEC filing on April 7, 2022.
Danos' colleagues
We found four more compensation records of executives who worked with Olivier Danos at Regenxbio in 2020.